Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026)

Compugen recorded quarterly Non-Current Deffered Revenue of $22.1 million in Q1 2026, down 11.24% quarter-over-quarter from $24.9 million in Q4 2025.

Compugen's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $22.1 million for Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $22.1 million; the TTM figure through Mar 2026 stood at $22.1 million (changed N/A YoY), while the FY2025 annual figure was $24.9 million, down 26.74% from the prior year.
  • Non-Current Deffered Revenue came in at $22.1 million for Q1 2026 at Compugen, down from $24.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $34.0 million in Q4 2024 to a low of $22.1 million in Q1 2026.
  • A 4-year average of $26.6 million and a median of $25.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue surged 34.08% in 2024 and slipped 26.74% in 2025, its largest moves.
  • Compugen's Non-Current Deffered Revenue stood at $25.4 million in 2023, then jumped by 34.08% to $34.0 million in 2024, then retreated by 26.74% to $24.9 million in 2025, then decreased by 11.24% to $22.1 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $22.1 million, $24.9 million, and $34.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 22.14 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.14 Mn
Dec 31, 2025 24.94 Mn
Sep 30, 2025 27.57 Mn
Jun 30, 2025 29.59 Mn
Mar 31, 2025 31.77 Mn
Dec 31, 2024 34.05 Mn
Sep 30, 2024 29.24 Mn
Jun 30, 2024 21.03 Mn
Mar 31, 2024 23.23 Mn
Dec 31, 2023 25.39 Mn
Dec 31, 2013 1.45 Mn